However, a small percentage of people experience persistent fatigue throughout treatment despite implementing all recommended strategies
This creates a smoother, more stable energy curve throughout your day
Phase 3 interim results of two new molecules were presented with simultaneous publications during Kidney Week
The GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and the GIP/GLP-1 dual agonist tirzepatide sit behind the STEP (NEJM, 2021), SURMOUNT (NEJM, 2022), and SURMOUNT-OSA (NEJM, 2024) evidence, and the clinical picture does not change with the price tag
Handling & storage Store the pen refrigerated at 28C, protect it from light, and keep it within the storage window printed on the COA